Respiri (KMLXF) Stock Price, News & Analysis

Company Overview

Respiri Limited is an Australian medical technology company focused on respiratory health and digital asthma management. The company develops and commercializes technologies designed to help patients, caregivers and healthcare professionals monitor respiratory symptoms and support more informed asthma management.

Its principal product is wheezo, a portable, smartphone-connected device that uses acoustic respiratory monitoring to detect wheeze. The accompanying wheezo application is designed to record respiratory information, track symptoms and medication use, and provide users with tools for ongoing asthma monitoring. Respiri has also developed related digital health services intended to connect patient-generated respiratory data with healthcare providers.

The company was formerly known as iSonea Limited and adopted the Respiri name as its business became more focused on respiratory monitoring and digital health. Respiri is headquartered in Australia and has pursued commercialization of its products in Australia and international markets, including the United States. Its technology is intended to complement, rather than replace, clinical assessment and treatment prescribed by qualified healthcare professionals.

Key Stats

• Today's Range: $0.0030 to $0.0030
• 50-Day Range: N/A
• 52-Week Range: $0.04 to $0.05
• Volume: N/A
• Average Volume: 6,100 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 9/27/2026
• Fiscal Year End: 6/30/2027

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Private Households
• Sub-Industry: Personal Services
• Current Symbol: OTCMKTS:KMLXF
• CIK: N/A
• Web: www.respiri.co
• Phone: 61 3 9653 9160
• Fax: 61 -0-3 9602 3606
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $1.07 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 0.07